274 related articles for article (PubMed ID: 32722967)
1. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
[TBL] [Abstract][Full Text] [Related]
2. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.
Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488
[TBL] [Abstract][Full Text] [Related]
3. Prediction of outcome using pretreatment
Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of FIGO staging defined by combining MRI and [
Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of ADC
Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
[TBL] [Abstract][Full Text] [Related]
7. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.
Han K; Croke J; Foltz W; Metser U; Xie J; Shek T; Driscoll B; Ménard C; Vines D; Coolens C; Simeonov A; Beiki-Ardakani A; Leung E; Levin W; Fyles A; Milosevic MF
Radiother Oncol; 2016 Sep; 120(3):519-525. PubMed ID: 27528120
[TBL] [Abstract][Full Text] [Related]
9. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
10. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of posttreatment
Lima GM; Matti A; Vara G; Dondi G; Naselli N; De Crescenzo EM; Morganti AG; Perrone AM; De Iaco P; Nanni C; Fanti S
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2139-2146. PubMed ID: 30069578
[TBL] [Abstract][Full Text] [Related]
13. Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.
Schurink NW; van Kranen SR; Berbee M; van Elmpt W; Bakers FCH; Roberti S; van Griethuysen JJM; Min LA; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2021 Sep; 31(9):7031-7038. PubMed ID: 33569624
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
Voglimacci M; Gabiache E; Lusque A; Ferron G; Ducassou A; Querleu D; Motton S; Chantalat E; Courbon F; Martinez A
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1551-1559. PubMed ID: 30729273
[TBL] [Abstract][Full Text] [Related]
15. Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
Leseur J; Roman-Jimenez G; Devillers A; Ospina-Arango JD; Williaume D; Castelli J; Terve P; Lavoue V; Garin E; Lejeune F; Acosta O; De Crevoisier R
Radiother Oncol; 2016 Sep; 120(3):512-518. PubMed ID: 27569847
[TBL] [Abstract][Full Text] [Related]
16. The role of
Rufini V; Collarino A; Calcagni ML; Meduri GM; Fuoco V; Pasciuto T; Testa AC; Ferrandina G; Gambacorta MA; Campitelli M; Gui B; Zannoni G; Manfredi R; Scambia G; Giordano A
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
Banks TI; von Eyben R; Hristov D; Kidd EA
Cancer Med; 2018 Aug; 7(8):3642-3651. PubMed ID: 29963760
[TBL] [Abstract][Full Text] [Related]
18. Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy.
Su TP; Lin G; Huang YT; Liu FY; Wang CC; Chao A; Chou HH; Yen TC; Lai CH
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):727-734. PubMed ID: 29159572
[TBL] [Abstract][Full Text] [Related]
19. False negative rate at
Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of diffusion-weighted magnetic resonance imaging and
Park JJ; Kim CK; Park BK
Radiother Oncol; 2016 Sep; 120(3):507-511. PubMed ID: 26900089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
